Behavioral obesity treatment produces clinically significant weight loss; for the greatest impact, it should be made available in the primary care setting where it can reach the many patients with overweight/obesity. The investigators developed a 3-month automated online behavioral weight loss program, Rx Weight Loss (RxWL), and showed that it produces clinically significant weight losses among primary care patients. The investigators' early efforts at pragmatic implementation of RxWL have been promising, and have shed light on challenges associated with implementation, and the need to study longer-term effectiveness. The investigators will therefore conduct a pragmatic study to improve the implementation and effectiveness of this behavioral obesity intervention delivered in routine and representative healthcare settings. The investigators are partnering with the Rhode Island Primary Care Physicians Corporation (RIPCPC), a large primary care network of 58 practices with 100 physicians and 16 nurse care managers. Using the framework for Effectiveness-Implementation Hybrid Designs, the investigators will simultaneously target effectiveness and implementation to maximize the public health impact of the research. Half of the 16 nurse care managers, and the practices they serve, will be randomized to either Basic Implementation (alerts generated using the electronic medical record \[EMR\] to direct eligible patients to RxWL), or to the Enhanced Implementation (alerts, clinician skills training to motivate and support weight loss, clinician dashboard with reports on patient progress and tools to facilitate patient engagement and behavior change). The investigators will test the hypothesis that the Enhanced Implementation will increase the proportion of patients directed to, enrolling, and completing the weight loss program. Because maintenance of weight loss is a critical problem, this project will also involve randomization of 600 patients with overweight/obesity and type 2 diabetes, hypertension, and/or hypercholesterolemia to the 3 month RxWL intervention followed by one of three maintenance conditions: (a) Control- 9 monthly online education sessions; (b) Monthly Lessons and Feedback- 9 monthly online video lessons teaching self-regulation with automated feedback on the self-monitoring record; (c) Refresher Campaigns- 9 monthly on-line video sessions, teaching self-regulation and providing two 4-week courses with novel strategies and behavioral challenges to improve long-term outcomes. The investigators will test the hypothesis that 12-month weight losses are better with Refresher Campaigns than Monthly Lessons and Feedback, and both are better than Control. Secondary outcomes include changes in weight, CVD risk factors, and medication use over a full 24 months. The project is significant and innovative because: it uses an empirically validated approach to obesity treatment that is integrated into the primary care setting, leveraging existing staff and EMR capabilities; it has a dual focus on improving effectiveness and implementation; it has a pragmatic design in partnership with a large primary care network that treats a diverse patient population; and it has potential to it provides a scalable, sustainable approach that can serve as a model for broader dissemination of obesity treatment intervention.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
600
Primary care clinic staff are trained to identify patients who meet study inclusion and exclusion criteria. They are then trained to provide patients with the information necessary to enroll in the study and access the online behavioral obesity treatment.
Primary care clinic staff are trained in psychological and behavioral strategies for: talking to patients about weight and weight loss in a way that patients find acceptable and helpful, increasing motivation for weight loss, overcoming common barriers to weight loss, and persevering with a weight loss attempt. They are trained in strategies to provide this support by telephone in addition to during clinic visits.
For 3 months, participants receive: a weekly online lessons for training in behavioral skills for losing weight; online self-monitoring of daily weight, diet, and physical activity; weekly feedback on the self-monitoring record.
After completing the 3-month Online Behavioral Weight Loss Intervention, participants receive 9 months of: monthly online newsletters with educational information pertaining to healthy weight, diet, and physical activity habits.
After completing the 3-month Online Behavioral Weight Loss Intervention, participants receive 9 months of: monthly online lessons for training in behavioral skills for maintaining weight loss and preventing weight gain; online self-monitoring of daily weight, diet, and physical activity; monthly feedback on the self-monitoring record.
After completing the 3-month Online Behavioral Weight Loss Intervention, participants receive two month-long refresher courses with weekly online lessons for training in behavioral skills for maintaining weight loss and preventing weight gain; online self-monitoring of daily weight, diet, and physical activity; weekly feedback on the self-monitoring record; weekly challenges focuses on specific behavior change and weight loss goals.
Weight Control and Diabetes Resarch Center
Providence, Rhode Island, United States
Change in Weight
Time frame: 12 months after study enrollment
Change in Weight
Time frame: 24 months after study enrollment
Proportion of Patients Achieving a Weight Loss of ≥5% of Initial Body Weight
Time frame: 12 and 24 months after study enrollment
Patient Satisfaction with the Treatment Program
Using a questionnaire developed for this study, patients are asked to rate their overall satisfaction with the treatment program, specific components of the treatment program, and the likelihood that they would recommend the program to family and friends, on a 5-point Likert scale ranging from 1 (Low) to 5 (High).
Time frame: 3 and 12 months after study enrollment
Provider Satisfaction with the Treatment Program
Using a questionnaire developed for this study, providers are asked to rate their overall satisfaction with the treatment program, and specific components of the treatment program, on a 5-point Likert scale ranging from 1 (Low) to 5 (High).
Time frame: 12 months after study enrollment
Proportion of Patients Deemed Eligible by the Electronic Medical Record Who are Directed to the Online Treatment Program
The proportion of patients who approached by clinic staff for potential participation in the study, out of the patients who are deemed potentially eligible in reports generated using the electronic medical record.
Time frame: 24 months after study initiation
Proportion of Patients That Enroll After Being Directed to the Online Treatment Program
The proportion of patients who enroll in the study out of the patients who are approached by clinic staff for potential participation in the study.
Time frame: 24 months after study initiation
Proportion of Enrolled Patients who Complete the Online Treatment Program
The proportion of patients who complete the initial 3-month weight loss treatment and following 9-month weight loss maintenance and weight gain prevention program, out of those that enroll.
Time frame: 24 months after study initiation
Clinician Contact with Patients Directed to the Online Treatment Program
Number and type of clinician contact with patients (e.g., clinic visits, phone calls).
Time frame: 24 months after study initiation
Patient Engagement and Adherence to the Online Intervention.
The online treatment platform automatically records all aspects of use including logins, lessons viewed, and self-monitoring records submitted.
Time frame: 12 months after study enrollment
Clinician Engagement with the Online Treatment Platform
Frequency and type of use (e.g., viewing patients progress metrics) of the online platform for tracking patient progress in the online treatment.
Time frame: 24 months after study initiation
Change in Low-density Lipoprotein (mg/dL)
Time frame: 12 and 24 months after study enrollment
Change in High-density Lipoprotein (mg/dL)
Time frame: 12 and 24 months after study enrollment
Change in Triglycerides (mg/dL)
Time frame: 12 and 24 months after study enrollment
Change in Blood Glucose (mg/dL)
Time frame: 12 and 24 months after study enrollment
Change in Glycated Haemoglobin (HbA1c)
Time frame: 12 and 24 months after study enrollment
Change in Systolic Blood Pressure (mmHG)
Time frame: 12 and 24 months after study enrollment
Change in Diastolic Blood Pressure (mmHG)
Time frame: 12 and 24 months after study enrollment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.